Jiebishe Carcinogen Contains Too High Pfizer Announces Recall of All Batches-News-Free Health

Pfizer’s smoking cessation drug Jiubishi film-coated tablets 0.5mg and 1mg, due to the high content of carcinogenic nitrosamines, Pfizer has announced a voluntary recall of all batches of the product. (Data photo)

[Real-time news/comprehensive report]Pfizer Pharmaceuticals produces 0.5 mg and 1 mg quit smoking drugs “Jibishi film-coated tablets”. Due to the high content of carcinogenic nitrosamines, Pfizer has announced a voluntary recall of all batches of products.

According to “NBC” reports, Pfizer initially suspended the delivery of problem drugs in June, and in August expanded the scope of removal to more batches of Jubishi, and now it is all recalled. The U.S. Food and Drug Administration (FDA) stated that people who have the recalled drug on hand can continue to take it until the pharmacist changes the drug or the doctor writes a different prescription and then changes the drug.

Please continue reading…

The FDA explained that taking these high levels of nitrosamines will not affect health immediately, and the health benefits of quitting smoking exceed the cancer risk caused by nitrosamine impurities. It is understood that Jibidong was approved by the FDA as a prescription drug in May 2006 to assist adults over 18 years of age to quit smoking. The course of treatment is about 12 to 24 weeks.

☆Health news is not missed, follow the fan page by likes.

☆For more important medical news, please visit FreeHealth.com.

No need to draw, no need to grab the news now, use the app to watch the news and ensure that you win every day. I download the app and follow me to see the activity method

.

The post Jiebishe Carcinogen Contains Too High Pfizer Announces Recall of All Batches-News-Free Health appeared first on Newsy Today.

Source link

Leave a Comment